(Q54071658)

24 May 2018

title

Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. (English)

1 reference

24 May 2018

main subject

cicatricial pemphigoid

1 reference

Foster CS

1

1 reference

24 May 2018

Ahmed AR

series ordinal

2

1 reference

24 May 2018

publication date

1 November 1999

1 reference

24 May 2018

published in

Ophthalmology

1 reference

24 May 2018

volume

106

1 reference

24 May 2018

issue

11

1 reference

24 May 2018

page(s)

2136-2143

1 reference

24 May 2018

Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Pathology of practolol-induced ocular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Idoxuridine-Induced Conjunctival Cicatrization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Induced ocular pseudopemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Preliminary serological studies comparing immunofluorescence assay with radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Azathioprine in the treatment of muco-cutaneous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Immunosuppressive therapy for progressive ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Systemic chemotherapy for ocular cicatricial pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Treatment of myasthenia gravis with high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990496-7

7 January 2021

10.1016/S0161-6420(99)90496-7

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018